Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment

被引：0
|
作者：
Cea, Michele
Cagnetta, Antonia [1 ]
Cirmena, Gabriella
Garuti, Anna
Rocco, Ilaria
Palermo, Claudia
Pierri, Ivana [2 ]
Gobbi, Marco [3 ]
Ballestrero, Alberto [4 ]
Nencioni, Alessio
Patrone, Franco [4 ]
Carella, Angelo Michele [5 ]
机构：
[1] Univ Genoa, Dept Hematol, Genoa, Italy
[2] Univ Genoa, Chair Hematol, Genoa, Italy
[3] Univ Genoa, Chair Haematol, Genoa, Italy
[4] Univ Genoa, Chair Internal Med, Genoa, Italy
[5] Osped San Martino Genova, Genoa, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [21] Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
    Hubert Hackl
    Ksenia Astanina
    Rotraud Wieser
    Journal of Hematology & Oncology, 10
  • [22] Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
    Hackl, Hubert
    Astanina, Ksenia
    Wieser, Rotraud
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [23] Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients
    SanMiguel, JF
    Martinez, A
    Macedo, A
    Vidriales, MB
    LopezBerges, C
    Gonzalez, M
    Cabaliero, D
    GarciaMarcos, MA
    Ramos, F
    FernandezCalvo, J
    Calmuntia, MJ
    DiazMediavilla, J
    Orfao, A
    BLOOD, 1997, 90 (06) : 2465 - 2470
  • [24] Molecular pathogenesis of tyrosine kinase resistance in chronic myeloid leukemia
    La Rosee, Paul
    Hochhaus, Andreas
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (02) : 91 - 96
  • [25] New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia
    Huang, Rui
    Kang, Qian
    Liu, Huimin
    Li, Yuhua
    CURRENT CANCER DRUG TARGETS, 2016, 16 (04) : 323 - 345
  • [26] Chronic arsenical poisoning during the treatment of chronic myeloid leukemia
    Kandel, EV
    LeRoy, GV
    ARCHIVES OF INTERNAL MEDICINE, 1937, 60 (05) : 846 - 866
  • [27] Value of molecular monitoring during the treatment of chronic myeloid leukemia: A Cancer and Leukemia Group B study
    Stock, W
    Westbrook, CA
    Peterson, B
    Arthur, DC
    Szatrowski, TP
    Silver, RT
    Sher, DA
    Wu, D
    LeBeau, MM
    Schiffer, CA
    Bloomfield, CD
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 26 - 36
  • [28] Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents
    Talati, Chetasi
    Pinilla-Ibarz, Javier
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (02) : 154 - 161
  • [29] Hedgehog pathway activation in chronic myeloid leukemia A promise for a novel combination therapeutic approach?
    Jagani, Zainab
    Dorsch, Marion
    Warmuth, Markus
    CELL CYCLE, 2010, 9 (17) : 3449 - 3456
  • [30] Treatment of chronic myeloid leukemia in relapse after umbilical cord blood transplantation
    Bogdanic, V
    Aurer, I
    Labar, B
    Hitrec, V
    Nemet, D
    Mrsic, M
    HAEMATOLOGICA, 1998, 83 (06) : 575 - 576
12345